SCHEMBL13634252

SCHEMBL13634252

Nc1ccccc1C(=O)N[C@H]1CC[C@@H](NC=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.49
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 2/20 0.48
P2RX7 Q99572 1/20 0.48
HTT P42858 1/20 0.48
GAA P10253 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PKM P14618 1/20 0.44
CNR1 P21554 3/20 0.43
CNR2 P34972 3/20 0.43
ADH1B P00325 1/20 0.42
ADH1A P07327 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2060435 0.91 CRBN (0.56) CRBNALDH1A1KDM4ENPC1RAB9A
Water SCHEMBL28110279 0.89 CRBN (0.55) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL28510668 0.84 CRBN (0.51) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL4960760 0.84 NPC1 (0.53) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL2771766 0.84 CRBN (0.51) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL2771765 0.84 CRBN (0.51) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL13161898 0.84 ALDH1A1 (0.61) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL22720116 0.84 ALDH1A1 (0.66) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL13634186 0.83 RAB9A (0.59) CRBNALDH1A1KDM4ENPC1RAB9A
SCHEMBL22720137 0.83 RAB9A (0.59) CRBNALDH1A1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed